Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,166,814 papers from all fields of science
Search
Sign In
Create Free Account
Bromocriptine
Known as:
Bromocriptin
, 2-Bromoergokryptine
, Bromoergocryptine
Expand
A semisynthetic, ergot alkaloid with antiparkinson and lactation inhibitory activities. Bromocriptine selectively binds to and activates the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
35 relations
Narrower (4)
2-Bromoergocryptine Mesylate
CB-154
Cycloset
Parlodel
Acromegaly
Amenorrhea
Bromocriptine 0.8 MG Oral Tablet [Cycloset]
Bromocriptine 2.5 MG Oral Tablet [Parlodel]
Expand
Broader (5)
Alkaloids
Antiparkinson Agents
Dopamine Agonists
Enzyme Inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.
S. Thobois
Clinical Therapeutics
2006
Corpus ID: 31935622
Highly Cited
2005
Highly Cited
2005
Agonism at 5-HT2B receptors is not a class effect of the ergolines.
S. Jähnichen
,
R. Horowski
,
H. Pertz
European Journal of Pharmacology
2005
Corpus ID: 43238378
Highly Cited
2001
Highly Cited
2001
Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances.
T. Wetter
,
C. Trenkwalder
,
O. Gershanik
,
B. Högl
Wiener Klinische Wochenschrift
2001
Corpus ID: 21620510
STUDY OBJECTIVE To assess the frequency of rapid eye movement (REM) sleep abnormalities in Parkinson's disease (PD) patients and…
Expand
Highly Cited
1983
Highly Cited
1983
Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.
P. Protais
,
I. Dubuc
,
J. Costentin
European Journal of Pharmacology
1983
Corpus ID: 4521467
Highly Cited
1982
Highly Cited
1982
Prolactin and luteinizing hormone secretion after bromocryptine (CB-154) treatment in lactating sows and ovariectomized gilts.
R. Kraeling
,
G. B. Rampacek
,
N. M. Cox
,
T. Kiser
Journal of Animal Science
1982
Corpus ID: 19325519
The effects of bromocryptine (CB-154) on prolactin (PRL) and luteinizing hormone (LH) secretion were studied in lactating sows…
Expand
Highly Cited
1981
Highly Cited
1981
Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
B. Costall
,
S. K. Lim
,
R. Naylor
European Journal of Pharmacology
1981
Corpus ID: 4592011
Highly Cited
1980
Highly Cited
1980
Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells.
R. Maurer
Journal of Biological Chemistry
1980
Corpus ID: 44696690
Highly Cited
1979
Highly Cited
1979
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
S. List
,
P. Seeman
Life Science
1979
Corpus ID: 34284346
Highly Cited
1976
Highly Cited
1976
Hyperprolactinemic male infertility.
S. Segal
,
W. Polishuk
,
M. Ben-david
Fertility and Sterility
1976
Corpus ID: 30267789
Highly Cited
1974
Highly Cited
1974
Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
A. Liuzzi
,
P. Chiodini
,
L. Botalla
,
F. Silvestrini
,
E. Müller
Journal of Clinical Endocrinology and Metabolism
1974
Corpus ID: 30205586
ABSTRACT In 29 acromegalic patients growth hormone (hGH) responses were studied following administration of synthetic TRH (200 μg…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE